These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 17414672)

  • 1. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study.
    de Simone G; Kitzman DW; Palmieri V; Liu JE; Oberman A; Hopkins PN; Bella JN; Rao DC; Arnett DK; Devereux RB
    Am J Hypertens; 2004 Sep; 17(9):828-33. PubMed ID: 15363827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of the appropriateness of left ventricular mass to left atrial size and function in arterial hypertension.
    Mureddu GF; Cioffi G; Stefenelli C; Boccanelli A
    J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):445-52. PubMed ID: 17502761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension.
    Ratto E; Leoncini G; Viazzi F; Bezante GP; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Feb; 26(2):345-50. PubMed ID: 18192849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
    Wachtell K; Papademetriou V; Smith G; Gerdts E; Dahlöf B; Engblom E; Aurigemma GP; Bella JN; Ibsen H; Rokkedal J; Devereux RB
    Am Heart J; 2004 Sep; 148(3):538-44. PubMed ID: 15389245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left ventricular hypertrophy in hypertension: functional aspects].
    Lombardo M; Zaini G; Colloca W; Belli C
    G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study.
    de Simone G; Kitzman DW; Chinali M; Oberman A; Hopkins PN; Rao DC; Arnett DK; Devereux RB
    Eur Heart J; 2005 May; 26(10):1039-45. PubMed ID: 15618056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
    Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension.
    Galderisi M; de Simone G; D'Errico A; Sidiropulos M; Viceconti R; Chinali M; Mondillo S; de Divitiis O
    Am J Hypertens; 2008 Sep; 21(9):1040-6. PubMed ID: 18600214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.
    Sesti G; Sciacqua A; Scozzafava A; Vatrano M; Angotti E; Ruberto C; Santillo E; Parlato G; Perticone F
    J Hypertens; 2007 Feb; 25(2):471-7. PubMed ID: 17211256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
    Edvardsen T; Rosen BD; Pan L; Jerosch-Herold M; Lai S; Hundley WG; Sinha S; Kronmal RA; Bluemke DA; Lima JA
    Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy.
    Mureddu GF; Pasanisi F; Palmieri V; Celentano A; Contaldo F; de Simone G
    J Hypertens; 2001 Jun; 19(6):1113-9. PubMed ID: 11403361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocardial versus midwall measurement of left ventricular function in mild hypertension: an insight from the Harvest Study.
    Palatini P; Visentin P; Nicolosi G; Mione V; Stritoni P; Michieletto M; Graniero G; Mormino P; Pessina AC
    J Hypertens; 1996 Aug; 14(8):1011-7. PubMed ID: 8884557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.